Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Disease Prevalence and Demographics: The prevalence of gastrointestinal diseases in Europe, the Middle East, and Africa has a major impact on the market for GI medications in these regions. The need for efficient GI drugs is influenced by a number of factors, including changing food preferences, lifestyle modifications, and aging populations.
Healthcare Infrastructure: The market for GI medications is heavily influenced by the caliber and accessibility of the healthcare infrastructure. Better diagnosis and treatment of gastrointestinal problems can be achieved in developed European countries thanks to their strong healthcare systems. Still, in other regions of Africa and the Middle East, inadequate healthcare infrastructure may hinder market expansion.
Regulatory Environment: Strict regulatory frameworks apply to the pharmaceutical industry, which includes GI medicines. The observance of laws established by health authorities in Europe, the Middle East, and Africa has an impact on pharmaceutical firms' market entrance tactics, approval procedures, and medication development.
Economic Factors: The market for gastrointestinal pharmaceuticals is influenced by a number of economic factors, such as GDP growth, healthcare spending, and medication affordability in the area. Economic downturns may impact market dynamics on patients' access to and affordability of pharmaceuticals.
Patient Education and Awareness: One important consideration is the general public's degree of knowledge and awareness regarding gastrointestinal health. The need for GI medications is fueled by patient education programs, awareness campaigns, and the work of medical professionals in promoting early diagnosis and treatment.
Technological Developments in Medicine: The diagnosis and management of gastrointestinal problems are impacted by developments in medical technology, including imaging methods and diagnostic instruments. Personalized medicine, medication delivery methods, and formulation innovations all support market expansion and competitiveness.
Cultural and food Influences: The incidence of gastrointestinal illnesses is influenced by a variety of cultural customs and food habits across Europe, the Middle East, and Africa. Pharmaceutical firms must take into account cultural issues that impact treatment adherence and modify medications to fit local food habits.
Europe Gastrointestinal Drugs Market Highlights:
Europe, Middle East and Africa Gastrointestinal Drugs Market Overview
The Europe Gastrointestinal Drugs Market Size was valued at USD 10.95 Billion in 2023. The Global Europe Gastrointestinal Drugs industry is projected to grow from USD 11.82 Billion in 2024 to USD 20.01 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.0% during the forecast period (2024 - 2032). Gastroesophageal reflux is the most common disease and is responsible for generating a good market. The major driving factor for this market are increasing prevalence of many gastrointestinal disease. In addition to this, technological advances, infrastructure development increasing investment in research activity and increasing awareness about the availability of treatment are responsible for providing fuel for the growth of the market. While incorrect self-diagnosis and availability of many misbranded drug are the major restraining factor for the growth of market.
Study Objectives Europe, Middle East and Africa Gastrointestinal Drugs Market Research Report
- Market Analysis of Europe, Middle East and Africa Gastrointestinal Drugs Market, with region assessment and competitive analysis.
- Detail market identification with its drivers and restrain of the market.
- To provide thorough understanding of various segment and sub segments of the market.
- Analysis of market on the basis of different factors like price analysis, supply chain analysis, porters five force analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to their main geographies and their countries
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Europe, Middle East and Africa Gastrointestinal Drugs Market.
- Information about the key companies that may influence this market in this region.
Key Players for Europe, Middle East and Africa Gastrointestinal Drugs market
AstraZeneca Plc.(UK), Johnson & Johnson (US), Takeda Pharmaceutical Company Limited (Japan), Eisai Co., Ltd. (Japan), Valeant Pharmaceuticals Inc. (US), Sanofi Ltd. (France), Valeant (US), Abbott Laboratories(US), Allergan Plc (US), Bayer AG (Germany), Janssen Biotech Inc. (US), AbbVie Inc. (US), Janssen Biotech (US), GlaxoSmithKline Plc. (UK), Boehringer Ingelheim GmbH (Germany).
Segmentation
Europe, Middle East and Africa gastrointestinal drugs market has been segmented on the basis of Drug Category they are segmented into Acid Neutralizers, Laxatives and Antidiarrheal, antiemetic, Anti-inflammatory drugs and other. Acid Neutralizers are further sub segmented into Antacids, H2 antagonists, Proton pump inhibitors and others. By Route of Administration they are segmented into Oral, Parenteral and rectal. By disease type they are segmented into Gastroesophageal Reflux Disease, Inflammatory Bowel Disease and Other. By End User Hospital Pharmacies, Retail Pharmacies and Other
Europe is the second major contributor in the GI drug market globally. Total Europe and Middle East and Africa GI drug market in 2016 was approximately USD$ 15 million. Germany and France are the major contributor of the market this is due to a huge number of patient suffering from different GI problems. About 9.2% of total population in France is suffering from acute or chronic GI problems. This is the major factor responsible for the growth of market. Due to saturation of market in this region the market is growing at a steady CAGR of 4.5 % during Forecast.
The report for Europe, Middle East and Africa Gastrointestinal Drugs Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Intended Audience
- Manufacturing industries.
- Pharmaceutical industry.
- Biotechnology Companies
- Research and Development (R&D) Companies
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
